The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarwyn Val. Regulatory News (MVI)

Share Price Information for Marwyn Val. (MVI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 94.50
Bid: 92.00
Ask: 97.00
Change: 0.00 (0.00%)
Spread: 5.00 (5.435%)
Open: 94.50
High: 94.50
Low: 94.50
Prev. Close: 94.50
MVI Live PriceLast checked at -
Marwyn Value Investors is an Investment Trust

To achieve long-term capital appreciation through its investment in the Master Fund primarily by focusing in mid cap businesses headquartered in the UK, Europe or North America.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Changes

10 Jul 2020 07:00

RNS Number : 6011S
Marwyn Value Investors Limited
10 July 2020
 

LEI: 213800L5751QTTVEA774

 

10 July 2020

 

MARWYN VALUE INVESTORS LIMITED (THE "COMPANY")

 

DIRECTOR CHANGES

 

The Company has conducted a review of its Board composition and is pleased to announce the following changes to the Board.

 

The Company announces the resignations of Ronald Hobbs (Independent Non-Executive Director) and Louisa Bonney (Non-Executive Director) with immediate effect and also announces the appointment, with immediate effect, of two new Directors:

 

Victoria Webster (Independent Non-Executive Director)

 

Victoria is a member of the Institute of Chartered Accountants in England and Wales having qualified with PricewaterhouseCoopers. She has worked in Guernsey, London and New York, specialising particularly in the audit of alternative investment funds. Victoria is a director of an independent chartered accountancy practice, Cleland & Co., which specialises in owner-managed companies and regulated entities across all sectors. She is a permanent resident of Guernsey.

 

Peter Rioda (Independent Non-Executive Director)

 

Peter is a qualified chartered accountant and independent non-executive director with over 25 years of industry experience who specialises in the establishment and management of alternative investment funds. He successfully established and developed Sanne Group's fund administration business between 2006 and 2016 exiting following its IPO in 2015. He has strong investment, risk management, governance and compliance skills acquired through directorships on a wide range of regulated and unregulated fund structures. He is regulated by the Jersey Financial Services Commission to act as a director. Peter is a leading figure in the Jersey funds industry and committee member of the Jersey Funds Association. 

 

Peter is the independent non-executive chairman of Marwyn General Partner II Limited (the general partner of Marwyn Value Investors II L.P.).

 

 

The changes to the composition of the Board detailed above, along with certain other updates in responsibilities, have resulted in the following:

 

Board independence

Three-quarters of the Board are now independent non-executive Directors, all of whom are also considered to be independent of the Manager.

 

Senior Independent Director

Martin Adams has been appointed Senior Independent Director.

 

Committee membership

Victoria Webster and Peter Rioda have been appointed to the Audit, Nomination and Remuneration Committees, with Victoria appointed as chair of the Audit Committee. All committees now comprise a majority of independent non-executive Directors.

 

Robert Ware, the Chairman of the Board commented:

 

"I would like to thank Ronald and Louisa for their valuable services to the Company over the years and, at the same time, welcome Victoria and Peter to the Board.

 

These changes in Directors result in a majority of the Board now being independent; Martin Adams being appointed Senior Independent Director and Victoria being appointed as chair of the Company's Audit Committee. The Company will benefit from enhanced oversight of the structure and activities through Peter's membership of the Board of the general partner of Marwyn Value Investors II L.P. through which key underlying investments are held."

 

 

 

Company enquiries:

 

Louisa Bonney / Scott Danks

Axio Capital Solutions Limited

Telephone: 01534 761240

 

Gillian Martin / Richard Bootle / Owen Matthews

Liberum Capital Limited

Telephone: 020 3100 2200

 

PR enquiries:

 

Alex Child-Villiers / Will Barker

Temple Bar Advisory

Telephone: 020 7975 1415

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABIGDRIBGDGGC
Date   Source Headline
3rd May 202211:12 amRNSNet Asset Value – 2016 Realisation Shares
3rd May 202211:11 amRNSNet Asset Value – Ordinary Shares
29th Apr 20227:00 amRNSAnnual Financial Statements December 2021
27th Apr 20227:00 amRNSInterim Dividend to Ordinary Shareholders
26th Apr 20225:48 pmRNSNet Asset Value – 2021 Realisation Shares
26th Apr 20225:46 pmRNSNet Asset Value – 2016 Realisation Shares
26th Apr 20225:43 pmRNSNet Asset Value – Ordinary Shares
21st Apr 202211:02 amRNSNotification of major interests in shares
21st Apr 202211:01 amRNSNotification of major interests in shares
20th Apr 20225:52 pmRNSShare Transfer
13th Apr 20221:04 pmRNSNet Asset Value – 2021 Realisation Shares
13th Apr 20221:01 pmRNSNet Asset Value – 2016 Realisation Shares
13th Apr 20221:00 pmRNSNet Asset Value – Ordinary Shares
1st Apr 202212:14 pmRNSNet Asset Value – 2021 Realisation Shares
1st Apr 202212:12 pmRNSNet Asset Value – 2016 Realisation Shares
1st Apr 202212:11 pmRNSNet Asset Value - Ordinary Shares
25th Mar 202212:37 pmRNSNet Asset Value - 2021 Realisation Shares
25th Mar 202212:34 pmRNSNet Asset Value - 2016 Realisation Shares
25th Mar 202212:31 pmRNSNet Asset Value - Ordinary Shares
14th Mar 20221:48 pmRNSNet Asset Value - 2021 Realisation Shares
14th Mar 20221:46 pmRNSNet Asset Value - 2016 Realisation Shares
14th Mar 20221:44 pmRNSNet Asset Value - Ordinary Shares
4th Mar 202210:21 amRNSNet Asset Value - 2021 Realisation Shares
4th Mar 202210:17 amRNSNet Asset Value - 2016 Realisation Shares
4th Mar 202210:14 amRNSNet Asset Value - Ordinary Shares
25th Feb 202211:18 amRNSNet Asset Value - 2021 Realisation Shares
25th Feb 202211:14 amRNSNet Asset Value - 2016 Realisation Shares
25th Feb 202211:10 amRNSNet Asset Value - Ordinary Shares
11th Feb 202210:16 amRNSNet Asset Value - 2021 Realisation Shares
11th Feb 202210:12 amRNSNet Asset Value - 2016 Realisation Shares
11th Feb 202210:04 amRNSNet Asset Value - Ordinary Shares
4th Feb 202212:07 pmRNSNet Asset Value - 2021 Realisation Shares
4th Feb 202212:04 pmRNSNet Asset Value - 2016 Realisation Shares
4th Feb 202212:02 pmRNSNet Asset Value - Ordinary Shares
28th Jan 202212:37 pmRNSNet Asset Value - 2021 Realisation Shares
28th Jan 202212:36 pmRNSNet Asset Value - 2016 Realisation Shares
28th Jan 202212:35 pmRNSNet Asset Value - Ordinary Shares
27th Jan 20227:00 amRNSInterim Dividend to Ordinary Shareholders
17th Jan 20222:43 pmRNSNet Asset Value - 2021 Realisation Shares
17th Jan 20222:39 pmRNSNet Asset Value - 2016 Realisation Shares
17th Jan 20222:35 pmRNSNet Asset Value - Ordinary Shares
7th Jan 20222:48 pmRNSAdvancedAdvT Potential Merger
30th Dec 202111:56 amRNSNet Asset Value - 2021 Realisation Shares
30th Dec 202111:55 amRNSNet Asset Value - 2016 Realisation Shares
30th Dec 202111:52 amRNSNet Asset Value - Ordinary Shares
24th Dec 20218:07 amRNSLaunch of MAC Alpha Limited
23rd Dec 20219:04 amRNSNet Asset Value - 2021 Realisation Shares
23rd Dec 20219:02 amRNSNet Asset Value - 2016 Realisation Shares
23rd Dec 20219:00 amRNSNet Asset Value - Ordinary Shares
14th Dec 202111:46 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.